Evidence map›Paper›PMID 32718587›Full record

ArticleBulletin du cancer

[A step forward for thromboembolic disease treatment in patients with cancer].

Xavier Mignard, Benjamin Planquette, Olivier Sanchez, Marie Wislez

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Bulletin du cancer. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Xavier MignardAH-HP, hôpital Cochin, Department of Respiratory Medicine, 75014 Paris, France.
Benjamin PlanquetteUniversité de Paris, Paris, France; Innovative Therapies in Haemostasis, Inserm, 75006 Paris, France; Biosurgical research lab (Carpentier Foundation), 75015 Paris, France; AH-HP, hôpital européen Georges-Pompidou, Department of Respiratory Medicine, 75015 Paris, France; FCRIN INNOVTE, Saint-Étienne, France.
Olivier SanchezUniversité de Paris, Paris, France; Innovative Therapies in Haemostasis, Inserm, 75006 Paris, France; Biosurgical research lab (Carpentier Foundation), 75015 Paris, France; AH-HP, hôpital européen Georges-Pompidou, Department of Respiratory Medicine, 75015 Paris, France; FCRIN INNOVTE, Saint-Étienne, France.
Marie WislezAH-HP, hôpital Cochin, Department of Respiratory Medicine, 75014 Paris, France; Université Paris Descartes, équipe « cancer, immune control and escape », centre de recherches des Cordeliers, Inserm U1138, Paris, France. Electronic address: marie.wislez@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsThromboembolismHumans

Identifiers

PMID32718587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.